Cargando…
_version_ 1784727750893895680
author Schimmer, Roman R.
Kovtonyuk, Larisa V.
Klemm, Nancy
Fullin, Jonas
Stolz, Sebastian M.
Mueller, Jan
Caiado, Francisco
Kurppa, Kari J.
Ebert, Benjamin L.
Manz, Markus G.
Boettcher, Steffen
author_facet Schimmer, Roman R.
Kovtonyuk, Larisa V.
Klemm, Nancy
Fullin, Jonas
Stolz, Sebastian M.
Mueller, Jan
Caiado, Francisco
Kurppa, Kari J.
Ebert, Benjamin L.
Manz, Markus G.
Boettcher, Steffen
author_sort Schimmer, Roman R.
collection PubMed
description
format Online
Article
Text
id pubmed-9198927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-91989272022-06-15 TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen Blood Adv Research Letter American Society of Hematology 2022-05-27 /pmc/articles/PMC9198927/ /pubmed/35026842 http://dx.doi.org/10.1182/bloodadvances.2021005859 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Schimmer, Roman R.
Kovtonyuk, Larisa V.
Klemm, Nancy
Fullin, Jonas
Stolz, Sebastian M.
Mueller, Jan
Caiado, Francisco
Kurppa, Kari J.
Ebert, Benjamin L.
Manz, Markus G.
Boettcher, Steffen
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title_full TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title_fullStr TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title_full_unstemmed TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title_short TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
title_sort tp53 mutations confer resistance to hypomethylating agents and bcl-2 inhibition in myeloid neoplasms
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198927/
https://www.ncbi.nlm.nih.gov/pubmed/35026842
http://dx.doi.org/10.1182/bloodadvances.2021005859
work_keys_str_mv AT schimmerromanr tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT kovtonyuklarisav tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT klemmnancy tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT fullinjonas tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT stolzsebastianm tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT muellerjan tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT caiadofrancisco tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT kurppakarij tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT ebertbenjaminl tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT manzmarkusg tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms
AT boettchersteffen tp53mutationsconferresistancetohypomethylatingagentsandbcl2inhibitioninmyeloidneoplasms